Canadian firm says it could make 10 million doses per month — if its innovative production method wins FDA approval.
The studies the FDA relied upon for its measles, mumps and rubella (MMR) vaccine approval was finally revealed two weeks ago. This after FOIA requests forced the FDA’s hand. The fact that this sunlight was delayed so long in itself points to massive corruption and unethical behavior. These studies should have been open sourced years ago and available to anybody.But we also learned that the FDA approval was only based on small, short-duration studies on 834 children — this for a vaccine that would be administered to hundreds of millions of children around the world. It compared contraindications for MMR compared with rubella only or with other lots of MMR. Not only were the study sizes criminally negligent, but they were never tested against a salient non-vaxxed control group. The study duration was a mere 42 days.